Fineotex Chemical Limited — Others, 12-08-2025: Appointment

The company has approved the financial results for the quarter ended June 30, 2025. Consolidated revenue grew 14.43% to ₹137.07 Cr, while Profit After Tax surged 24.34% to ₹25.03 Cr, driven by a 14.73% volume increase and 18.37% operational EBITDA growth to ₹25.20 Cr. Operationally, the new Ambernath manufacturing facility, adding 300,000 sq ft, has commenced commercial production, enhancing capacity and product offerings. The 22nd Annual General Meeting will be held on September 19, 2025. Key appointments, including a new Secretarial Auditor and an Independent Director, Mr. Chetan Shah, were approved, pending shareholder sanction.